Stifel Starts Celcuity Inc (CELC) at Buy, 'A Superior Breast Cancer Drug'
Tweet Send to a Friend
(Updated - February 21, 2024 4:07 PM EST)
Stifel analyst Bradley Canino initiates coverage on Celcuity Inc (NASDAQ: CELC) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Stifel analyst Bradley Canino initiates coverage on Celcuity Inc (NASDAQ: CELC) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
